Investigation of properties and recrystallisation behaviour of amorphous indomethacin samples prepared by different methods

International Journal of Pharmaceutics

Volumn 417, Issue 1-2, 2011, Pages 94-100

  Karmwar, Pranav ^a   Graeser, Kirsten ^a   Gordon, Keith C ^a   Strachan, Clare J ^a   Rades, Thomas ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Amorphous; Indomethacin; Molecular mobility; Solid state transformation; Stability; Structural relaxation

Indexed keywords

INDOMETACIN;

ARTICLE; CONFORMATION; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TRANSFORMATION; MOLECULAR INTERACTION; NONPHOTOCHEMICAL QUENCHING; PRIORITY JOURNAL; RAMAN SPECTROMETRY; SPRAY DRYING; THERMAL ANALYSIS; VIBRATION; X RAY DIFFRACTION;

CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; CRYSTALLIZATION; DRUG STABILITY; INDOMETHACIN; SPECTRUM ANALYSIS, RAMAN; X-RAY DIFFRACTION;

EID: 80052268779     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.12.019     Document Type: Article

References (30)

1. G. Adam, and J.H. Gibbs On the temperature dependence of cooperative relaxation properties in glass-forming liquids J. Chem. Phys. 43 1965 139 146
2. D.J. Allen, and K.C. Kwan Determination of degree of crystallinity in solid-solid equilibria J. Pharm. Sci. 58 1969 1190 1193
3. G.L. Amidon, H. Lennernas, V.P. Shah, and J.R. Crison A theoretical basis for a biopharmaceutic drug classification - the correlation of in-vitro drug product dissolution and in-vivo bioavailability Pharm. Res. 12 1995 413 420
4. C. Bhugra, R. Shmeis, S.L. Krill, and M.J. Pikal Prediction of onset of crystallization from experimental relaxation times. II. Comparison between predicted and experimental onset times J. Pharm. Sci. 97 2008 455 472
5. L. Borka Polymorphism of indomethacin - new modifications, their melting behavior and solubility Acta Pharm. Suec. 11 1974 295 303
6. P.J. Cox, and P.L. Manson Indomethacin tert-butanol solvate at 120 K Acta Crystallogr. E 59 2003 O1189 O1191
7. D.Q.M. Craig, P.G. Royall, V.L. Kett, and M.L. Hopton The relevance of the amorphous state to pharmaceutical dosage forms: glassy drugs and freeze dried systems Int. J. Pharm. 179 1999 179 207 (Pubitemid 29131430)
8. T. Feng, R. Pinal, and M.T. Carvajal Process induced disorder in crystalline materials: differentiating defective crystals from the amorphous form of griseofulvin J. Pharm. Sci. 97 2008 3207 3221
9. K.A. Graeser, J.E. Patterson, and T. Rades Applying thermodynamic and kinetic parameters to predict the physical stability of two differently prepared amorphous forms of simvastatin Curr. Drug Deliv. 6 2009 374 382
10. K.A. Graeser, C.J. Strachan, J.E. Patterson, K.C. Gordon, and T. Rades Physicochemical properties and stability of two differently prepared amorphous forms of simvastatin Cryst. Growth Des. 8 2008 128 135
11. B.C. Hancock, and G. Zograf Characteristics and significance of the amorphous state in pharmaceutical systems J. Pharm. Sci. 86 1997 1 12
12. B.C. Hancock, and G. Zografi Effects of solid-state processing on water vapor sorption by aspirin J. Pharm. Sci. 85 1996 246 248 (Pubitemid 26055809)
13. A. Heinz, M. Savolainen, T. Rades, and C.J. Strachan Quantifying ternary mixtures of different solid-state forms of indomethacin by Raman and near-infrared spectroscopy Eur. J. Pharm. Sci. 32 2007 182 192 (Pubitemid 47532710)
14. L.R. Hilden, and K.R. Morris Physics of amorphous solids J. Pharm. Sci. 93 2004 3 12 (Pubitemid 38087927)
15. H. Imaizumi, N. Nambu, and T. Nagai Stability and several physical properties of amorphous and crystalline forms of indomethacin Chem. Pharm. Bull. 28 1980 2565 2569 (Pubitemid 11208718)
16. N. Kaneniwa, M. Otsuka, and T. Hayashi Physicochemical characterization of indomethacin polymorphs and the transformation kinetics in ethanol Chem. Pharm. Bull. 33 1985 3447 3455 (Pubitemid 16228015)
17. J. Liu, D.R. Rigsbee, C. Stotz, and M.J. Pikal Dynamics of pharmaceutical amorphous solids: the study of enthalpy relaxation by isothermal microcalorimetry J. Pharm. Sci. 91 2002 1853 1862 (Pubitemid 34810530)
18. C. Mao, S. Prasanth Chamarthy, S. Byrn, and R. Pinal A calorimetric method to estimate molecular mobility of amorphous solids at relatively low temperatures Pharm. Res. 23 2006 2269 2276 (Pubitemid 44511508)
19. L. Olivares-Quiroz, and L.S. Garcia-Colin Evidence of [alpha] fluctuations in myoglobin's denaturation in the high temperature region: average relaxation time from an Adam-Gibbs perspective Biophys. Chem. 144 2009 123 129
20. M. Savolainen, A. Heinz, C. Strachan, K.C. Gordon, J. Yliruusi, T. Rades, and N. Sandler Screening for differences in the amorphous state of indomethacin using multivariate visualization Eur. J. Pharm. Sci. 30 2007 113 123 (Pubitemid 46149278)
21. M. Savolainen, A. Heinz, C. Strachan, J. Yliruusi, T. Rades, and N. Sandler Screening for differences in the amorphous state of indomethacin using multivariate visualization Eur. J. Pharm. Sci. 32 2007 S8
22. T.Y. Shen, S. Lucas, L.H. Sarett, A. Rosegray, G.W. Nuss, J.D. Willett, R.L. Ellis, F.W. Holly, A.R. Matzuk, A.N. Wilson, C.A. Winter, T.B. Windholz, E.A. Risley, C.H. Stammer, W.J. Holtz, and B.E. Witzel Non-steroid anti-inflammatory agents J. Am. Chem. Soc. 85 1963 488 489
23. C.J. Strachan, T. Rades, and K.C. Gordon A theoretical and spectroscopic study of gamma-crystalline and amorphous indomethacin J. Pharm. Pharmacol. 59 2007 261 269 (Pubitemid 46203064)
24. R. Surana, A. Pyne, M. Rani, and R. Suryanarayanan Measurement of enthalpic relaxation by differential scanning calorimetry - effect of experimental conditions Thermochim. Acta 433 2005 173 182 (Pubitemid 40891598)
25. L.S. Taylor, and G. Zografi Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions Pharm. Res. 14 1997 1691 1698 (Pubitemid 28062912)
26. G. Van den Mooter, P. Augustijns, and R. Kinget Stability prediction of amorphous benzodiazepines by calculation of the mean relaxation time constant using the Williams-Watts decay function Eur. J. Pharm. Biopharm. 48 1999 43 48 (Pubitemid 29308924)
27. C.A. Winter, E.A. Risley, and G.W. Nuss Anti-inflammatory and antipyretic activities of indo-methacin, 1-(p-chlorobenzoyl)-5-methoxy-2-methyl-indole-3- acetic acid J. Pharmacol. Exp. Ther. 141 1963 369 376
28. H. Yamamoto 1-Acyl-indoles. 2. A new synthesis of 1-(p-chlorobenzoyl)-5- methoxy-3-indolylacetic acid and its polymorphism Chem. Pharm. Bull. 16 1968 17 19
29. S. Yoshioka, Y. Aso, and S. Kojima Usefulness of the Kohlrausch-Williams- Watts stretched exponential function to describe protein aggregation in lyophilized formulations and the temperature dependence near the glass transition temperature Pharm. Res. 18 2001 256 260 (Pubitemid 32595810)
30. L. Yu Amorphous pharmaceutical solids: preparation, characterization and stabilization Adv. Drug Deliv. Rev. 48 2001 27 42 (Pubitemid 32454482)